Discover the booming Sodium Iodide (I-131) Solutions market. This comprehensive analysis reveals a $500 million market in 2025, projected to reach $900 million by 2033, driven by rising thyroid cancer and hyperthyroidism rates and advancements in nuclear medicine. Explore market trends, segmentation, key players (Jubilant Pharmova, China Tongfu), and regional insights.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.